Literature DB >> 20533997

Nurr1 regulates RET expression in dopamine neurons of adult rat midbrain.

Danny Galleguillos1, José A Fuentealba, Luis M Gómez, Mathias Saver, Andrea Gómez, Kevin Nash, Corinna Burger, Katia Gysling, María E Andrés.   

Abstract

Genesis of midbrain dopamine (DA) neurons depends on Nurr1, a nuclear receptor expressed during development and adulthood in these neurons. Nurr1 is required for the expression of genes of dopaminergic phenotype such as tyrosine hydroxylase and DA transporter. The expression of the tyrosine kinase receptor RET also depends on Nurr1 during development. However, it is unknown whether RET expression is regulated by Nurr1 during adulthood, and the mechanism by which Nurr1 regulates RET expression. Using an adeno-associated vector-delivered anti-Nurr1 ribozyme, we knocked-down Nurr1 expression unilaterally in the substantia nigra (SN) of adult rats. Animals injected with the ribozyme displayed a 57.3% decrease in Nurr1 mRNA in the SN accompanied by decreased DA extracellular levels in the striatum. RET mRNA in the injected SN and RET protein in the ipsilateral striatum decreased 76.9% and 47%, respectively. Tyrosine hydroxylase and DA transporter mRNA did not change in Nurr1 knocked-down SN. Nurr1 induced the transcription of the human RET promoter in cell type and concentration-dependent manner. Nurr1 induction of RET promoter is independent of NBRE elements. These results show that the expression of RET in rat adult SN is regulated by Nurr1 and suggest that RET is a transcriptional target of this nuclear receptor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20533997     DOI: 10.1111/j.1471-4159.2010.06841.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

Review 1.  NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.

Authors:  Mickael Decressac; Nikolaos Volakakis; Anders Björklund; Thomas Perlmann
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

2.  Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease.

Authors:  Krista McFarland; Tracy A Spalding; David Hubbard; Jian-Nong Ma; Roger Olsson; Ethan S Burstein
Journal:  ACS Chem Neurosci       Date:  2013-10-11       Impact factor: 4.418

3.  4-amino-7-chloroquinoline derivatives for treating Parkinson's disease: implications for drug discovery.

Authors:  Chun-Hyung Kim; Pierre Leblanc; Kwang-Soo Kim
Journal:  Expert Opin Drug Discov       Date:  2016-03-07       Impact factor: 6.098

4.  Activation of Peroxisome Proliferator-Activated Receptor-α Increases the Expression of Nuclear Receptor Related 1 Protein (Nurr1) in Dopaminergic Neurons.

Authors:  Carl G Gottschalk; Avik Roy; Malabendu Jana; Madhuchhanda Kundu; Kalipada Pahan
Journal:  Mol Neurobiol       Date:  2019-05-24       Impact factor: 5.590

5.  Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite.

Authors:  John M Bruning; Yan Wang; Francesca Oltrabella; Boxue Tian; Svetlana A Kholodar; Harrison Liu; Paulomi Bhattacharya; Su Guo; James M Holton; Robert J Fletterick; Matthew P Jacobson; Pamela M England
Journal:  Cell Chem Biol       Date:  2019-03-07       Impact factor: 8.116

6.  Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.

Authors:  Yaping Chu; Scott Muller; Adriana Tavares; Olivier Barret; David Alagille; John Seibyl; Gilles Tamagnan; Ken Marek; Kelvin C Luk; John Q Trojanowski; Virginia M Y Lee; Jeffrey H Kordower
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

7.  Differential properties of transcriptional complexes formed by the CoREST family.

Authors:  Álvaro P Barrios; Andrea V Gómez; Julián E Sáez; Giuseppe Ciossani; Emanuela Toffolo; Elena Battaglioli; Andrea Mattevi; María E Andrés
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

Review 8.  Dissecting the role of Engrailed in adult dopaminergic neurons--Insights into Parkinson disease pathogenesis.

Authors:  Hocine Rekaik; François-Xavier Blaudin de Thé; Alain Prochiantz; Julia Fuchs; Rajiv L Joshi
Journal:  FEBS Lett       Date:  2015-10-13       Impact factor: 4.124

9.  Evidence for transcriptional factor dysregulation in the dorsal raphe nucleus of patients with major depressive disorder.

Authors:  Ilan A Kerman; René Bernard; William E Bunney; Edward G Jones; Alan F Schatzberg; Richard M Myers; Jack D Barchas; Huda Akil; Stanley J Watson; Robert C Thompson
Journal:  Front Neurosci       Date:  2012-10-18       Impact factor: 4.677

10.  PIASγ enhanced SUMO-2 modification of Nurr1 activation-function-1 domain limits Nurr1 transcriptional synergy.

Authors:  Cristian Arredondo; Marcelo Orellana; Andrea Vecchiola; Luis Alberto Pereira; Leopoldo Galdames; María Estela Andrés
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.